Eyenovia Inc (NAS:EYEN)
$ 0.77 0.0326 (4.42%) Market Cap: 41.48 Mil Enterprise Value: 48.38 Mil PE Ratio: 0 PB Ratio: 19.25 GF Score: 21/100

Eyenovia, Inc. - Special Call Transcript

Oct 13, 2020 / 08:30PM GMT
Release Date Price: $3.59 (+0.28%)
Operator

Greetings and welcome to Eyenovia Corporate Update Conference Call. (Operator Instructions) Please note, this conference is being recorded.

I would now like to turn the conference over to your host, Eric Ribner, Investor Relations. Thank you. You may begin.

Eric Ribner
LifeSci Advisors - Managing Director

Good afternoon and welcome to Eyenovia's conference call to discuss the company's exclusive license agreement with Bausch + Lomb, and both companies -- that both companies announced yesterday, along with Eyenovia's other recent business development activities.

With me today are Dr. Sean Ianchulev, Eyenovia's Chief Executive Officer and Chief Medical Officer; Michael Rowe, Eyenovia's Vice President of Commercial; and John Gandolfo, Eyenovia's Chief Financial Officer.

Except for historical information, all of the statements, expectations and assumptions contained in this conference call are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot